Type 2 Diabetes

30 competing products in clinical development for Type 2 Diabetes.

Pipeline by Phase

Pre-clinical5

Phase 15

Phase 24

Phase 2/32

Phase 39

Approved5

All Products (30)

Product	Company	Stage	Status	Hype
Pioglitazone 15 MG [Actos] + Empagliflozin 10 MG [Jardiance] + Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Actos]	Celltrion	Approved	Recruiting	50
insulin lispro protamine suspension:insulin lispro rDNA origin low mix + insulin glargine	Eli Lilly	Approved	Completed	43
Lispro mix 75/25 + Glargine	Eli Lilly	Approved	Completed	43
Colesevelam + Metformin	Daiichi Sankyo	Approved	Completed	43
Amlodipine + amlodipine / olmesartan medoxomil combination + Hydrochlorothiazide	Daiichi Sankyo	Approved	Completed	43
Tirzepatide + Semaglutide	Eli Lilly	Phase 3	Completed	40
Orforglipron	Eli Lilly	Phase 3	Completed	40
Colesevelam HCl + rosiglitazone maleate + sitagliptin phosphate	Daiichi Sankyo	Phase 3	Completed	40
Colesevelam hydrochloride	Daiichi Sankyo	Phase 3	Completed	40
Colesevelam hydrochloride	Daiichi Sankyo	Phase 3	Completed	40
Colesevelam hydrochloride	Daiichi Sankyo	Phase 3	Completed	40
Colesevelam hydrochloride	Daiichi Sankyo	Phase 3	Completed	40
OPC-262	Kyowa Kirin	Phase 3	Completed	40
MK-0431/ONO-5435 + Placebo, MK-0431/ONO-5435	Ono Pharmaceutical	Phase 3	Completed	40
colesevelam HCl + placebo	Daiichi Sankyo	Phase 2/3	Completed	38
Rivoglitazone + Pioglitazone + Placebo	Daiichi Sankyo	Phase 2/3	Completed	38
Dulaglutide + Placebo	Eli Lilly	Phase 2	Completed	35
Rivoglitazone HCl + rivoglitazone HCl + rivoglitazone HCl + Placebo	Daiichi Sankyo	Phase 2	Completed	35
Rivoglitazone HCl + rivoglitazone HCl + rivoglitazone HCl + pioglitazone HCl + placebo	Daiichi Sankyo	Phase 2	Completed	35
Colesevelam + Colesevelam matching placebo + Insulin glargine (Lantus)	Daiichi Sankyo	Phase 2	Completed	35
Dual-combination therapy + Triple-combination therapy	Celltrion	Pre-clinical	Recruiting	33
Metformin	Torrent Pharmaceuticals	Phase 1	Completed	29
Metformin	Torrent Pharmaceuticals	Phase 1	Completed	29
Metformin	Torrent Pharmaceuticals	Phase 1	Completed	29
Metformin	Torrent Pharmaceuticals	Phase 1	Completed	29
Empagliflozin + Other SGLT2 inhibitors + Other non-insulin GLDs	Eli Lilly	Pre-clinical	Completed	26
Exenatide + Placebo	Eli Lilly	Pre-clinical	Completed	26
ipragliflozin	Astellas Pharma	Pre-clinical	Completed	26
Suglat®	Astellas Pharma	Pre-clinical	Completed	26
NEX-22A, a prolonged release formulation of liraglutide	Nanexa AB	Phase 1	Completed	23